TENTECH is setting out to expand into the global market after being successively selected for major overseas expansion support projects organized by the government and related agencies.

TENTECH announced on the 21st that it was simultaneously selected for the ‘2026 Global IP Star Enterprise Development Project’ by the Regional Intellectual Property Centers under the Korean Intellectual Property Office and the ‘2026 Biohealth Global Expansion Support Project’ organized by the Korea Health Industry Development Institute.

First, the ‘Global IP Star Enterprise Development Project’ is a program that identifies promising small and medium-sized enterprises (SMEs) with export capabilities and provides comprehensive support for intellectual property (IP) related services for three years. Through this selection, TENTECH will receive support over the next three years for overseas patent and trademark applications and registrations in major export countries such as the U.S., Europe, China, and Japan, as well as design development and the establishment of IP management strategies.

Using this as a springboard, TENTECH plans to strengthen its overseas patent portfolio related to its core technologies, RF and HIFU. It is expected that this will help secure IP competitiveness to counter technological pursuit by latecomers, while simultaneously enhancing credibility as a medical device brand in the global market.

The simultaneously selected ‘Biohealth Global Expansion Support Project’ is a program that supports domestic medical device companies in operating training programs for local medical professionals by utilizing overseas medical institutions or cadaver labs.

Through this project, TenTech will receive support for various expenses necessary for local training, such as venue rental and inviting speakers. The company plans to introduce the clinical advantages of its products to international experts and establish a foundation for expanding exports by providing locally tailored educational content.

TenTech CEO Han Dong-ok stated, “With the selection for this government support project, we have gained significant momentum for expanding into the global market.” He added, “Based on this momentum, we will strengthen the IP rights of our core technologies, establish ourselves as a brand trusted by medical professionals around the world, and expand our presence in the global medical aesthetics market.”